Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
0DeX0j2w0THsS7XK
